default author photo

Min Xiao

Huazhong University of Science and Technology - Department of Hematology

China

SCHOLARLY PAPERS

2

DOWNLOADS

239

TOTAL CITATIONS

3

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

The Utility of Non-Invasive Liquid Biopsy for Mutational Analysis and Minimal Residual Disease Assessment in Extramedullary Multiple Myeloma

Number of pages: 40 Posted: 22 Aug 2019
Xiaolu Long, Qian Xu, Yaoyao Lou, Chunrui Li, Jia Gu, Haodong Cai, Di Wang, Jinhuan Xu, Tongjuan Li, Xiaoxi Zhou, Min Xiao, Ying Wang, Xia Mao, Jianfeng Zhou and Liting Chen
Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Cancer Biology Research Center and Huazhong University of Science and Technology - Department of Hematology
Downloads 147 (502,974)
Citation 1

Abstract:

Loading...

Extramedullary myeloma; liquid biopsy; circulating tumor DNA; targeted next-generation sequencing; droplet digital PCR

2.

Anti-BCMA CAR T-Cell Therapy in Relapsed or Refractory Multiple Myeloma with Extramedullary Disease and Plasma Cell Leukemia

Number of pages: 44 Posted: 17 Dec 2019
Chunrui Li, Wenyue Cao, Qiuxiang Wang, Yi Xiao, Chaojiang Gu, Di Wang, Jue Wang, Lijun Jiang, Hao Xu, Jinhuan Xu, Xiaoxi Zhou, Zhenya Hong, Na Wang, Liang Huang, Shangkun Zhang, Liting Chen, Xia Mao, Min Xiao, Wei Zhang, Li Meng, Yang Cao, Tongcun Zhang, Jian Li and Jianfeng Zhou
Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Wuhan No. 1 Hospital, Huazhong University of Science and Technology - Department of Hematology, Wuhan University of Science and Technology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Wuhan University of Science and Technology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Department of Hematology, Wuhan University of Science and Technology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Hematology and Huazhong University of Science and Technology - Department of Hematology
Downloads 92 (730,864)
Citation 2

Abstract:

Loading...

Anti-BCMA CAR T-Cell; Relapsed or Refractory; Multiple Myeloma; Extramedullary disease